These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 35723859)

  • 1. Hypoglycaemic therapy in frail older people with type 2 diabetes mellitus-a choice determined by metabolic phenotype.
    Sinclair AJ; Pennells D; Abdelhafiz AH
    Aging Clin Exp Res; 2022 Sep; 34(9):1949-1967. PubMed ID: 35723859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New hypoglycaemic therapy in frail older people with diabetes mellitus-phenotypic status likely to be more important than functional status.
    Abdelhafiz AH; Emmerton D; Sinclair AJ
    Diabetes Res Clin Pract; 2020 Nov; 169():108438. PubMed ID: 32920102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Type 2 Diabetes in Frail Older Adults.
    Bahat G; Ozkok S; Petrovic M
    Drugs Aging; 2023 Sep; 40(9):751-761. PubMed ID: 37434085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk reduction in older people with type 2 diabetes mellitus-a comprehensive narrative review.
    Si PEH; Parker S; Abdelhafiz D; Summerbell A; Muzulu S; Abdelhafiz AH
    Diabetes Res Clin Pract; 2024 May; 211():111662. PubMed ID: 38599285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outcome of frailty in older people with diabetes as a function of glycaemic control and hypoglycaemic therapy: a review.
    Keegan GL; Bhardwaj N; Abdelhafiz AH
    Expert Rev Endocrinol Metab; 2023; 18(5):361-375. PubMed ID: 37489773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Impact of Frailty Changes Diabetes Trajectory.
    Sinclair AJ; Abdelhafiz AH
    Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Characteristics of Frail Older People with Diabetes Mellitus-A Systematic Search for Phenotypes.
    Abdelhafiz AH; Keegan GL; Sinclair AJ
    Metabolites; 2023 May; 13(6):. PubMed ID: 37367862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer anti-diabetic therapies with low hypoglycemic risk-potential advantages for frail older people.
    Emmerton D; Abdelhafiz A
    Hosp Pract (1995); 2021 Aug; 49(3):164-175. PubMed ID: 33729898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frailty and safety: the example of diabetes.
    Abbatecola AM; Olivieri F; Corsonello A; Strollo F; Fumagalli A; Lattanzio F
    Drug Saf; 2012 Jan; 35 Suppl 1():63-71. PubMed ID: 23446787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-renal protection in older people with diabetes with frailty and medical comorbidities - A focus on the new hypoglycaemic therapy.
    Abdelhafiz AH; Sinclair AJ
    J Diabetes Complications; 2020 Sep; 34(9):107639. PubMed ID: 32595017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypoglycaemic therapy on frailty: a multi-dimensional perspective.
    Abdelhafiz AH
    Expert Rev Endocrinol Metab; 2023 Jan; 18(1):53-65. PubMed ID: 36650694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of frailty metabolic phenotypes on the management of older people with type 2 diabetes mellitus.
    Abdelhafiz AH; Emmerton D; Sinclair AJ
    Geriatr Gerontol Int; 2021 Aug; 21(8):614-622. PubMed ID: 34151494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic phenotypes explain the relationship between dysglycaemia and frailty in older people with type 2 diabetes.
    Abdelhafiz AH; Sinclair AJ
    J Diabetes Complications; 2022 Apr; 36(4):108144. PubMed ID: 35151546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age--An overview.
    Buch A; Carmeli E; Boker LK; Marcus Y; Shefer G; Kis O; Berner Y; Stern N
    Exp Gerontol; 2016 Apr; 76():25-32. PubMed ID: 26785313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty predicts adverse outcomes in older people with diabetes.
    Ulley J; Abdelhafiz AH
    Practitioner; 2017 Jan; 261(1800):17-20. PubMed ID: 29023081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations on glycaemic control in older and/or frail individuals with diabetes and advanced kidney disease.
    Panduru NM; Nistor I; Groop PH; Van Biesen W; Farrington K; Covic A
    Nephrol Dial Transplant; 2017 Apr; 32(4):591-597. PubMed ID: 28340246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycaemia and its management in primary care setting.
    Ibrahim M; Baker J; Cahn A; Eckel RH; El Sayed NA; Fischl AH; Gaede P; Leslie RD; Pieralice S; Tuccinardi D; Pozzilli P; Richelsen B; Roitman E; Standl E; Toledano Y; Tuomilehto J; Weber SL; Umpierrez GE
    Diabetes Metab Res Rev; 2020 Nov; 36(8):e3332. PubMed ID: 32343474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender Differences in Body Composition in Pre-Frail Older Adults With Diabetes Mellitus.
    Merchant RA; Soong JTY; Morley JE
    Front Endocrinol (Lausanne); 2022; 13():795594. PubMed ID: 35242108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies.
    Abbatecola AM; Maggi S; Paolisso G
    Drugs Aging; 2008; 25(11):913-25. PubMed ID: 18947259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.